Alternative splicing of immune-related genes identifies breast cancer subtypes with differential immune cell infiltration.
作者信息
Zhao Zhangxiang, Wang Yuquan, Jin Zixin, Han Huiming, Chen Bo, Liu Mingyue, Liu Kaidong, Zhuang Shuping, Liang Haihai, Gu Yunyan
机构信息
The Sino-Russian Medical Research Center of Jinan University, The Institute of Chronic Disease of Jinan University, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, China.
Department of Pharmacology (State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, Heilongjiang 150081, China.
出版信息
Genes Dis. 2024 Jun 14;12(2):101349. doi: 10.1016/j.gendis.2024.101349. eCollection 2025 Mar.
Abstract
摘要
相似文献
1
Alternative splicing of immune-related genes identifies breast cancer subtypes with differential immune cell infiltration.
Genes Dis. 2024 Jun 14;12(2):101349. doi: 10.1016/j.gendis.2024.101349. eCollection 2025 Mar.
2
Clinical and Prognostic Implications of an Alternative Splicing-related Risk Model Based on TP53 Status in Breast Cancer.
Curr Pharm Biotechnol. 2025;26(2):246-259. doi: 10.2174/0113892010283176240212073417.
3
Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer.
Front Genet. 2021 Jun 14;12:686298. doi: 10.3389/fgene.2021.686298. eCollection 2021.
4
Clinically relevant immune subtypes based on alternative splicing landscape of immune-related genes for lung cancer advanced PPPM approach.
EPMA J. 2024 May 24;15(2):345-373. doi: 10.1007/s13167-024-00366-4. eCollection 2024 Jun.
5
Novel prognostic alternative splicing events in colorectal Cancer: Impact on immune infiltration and therapy response.
Int Immunopharmacol. 2024 Sep 30;139:112603. doi: 10.1016/j.intimp.2024.112603. Epub 2024 Jul 22.
6
Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
J Transl Med. 2020 Jul 28;18(1):286. doi: 10.1186/s12967-020-02454-1.
7
Alternative Splicing Events in Tumor Immune Infiltration in Colorectal Cancer.
Front Oncol. 2021 Apr 29;11:583547. doi: 10.3389/fonc.2021.583547. eCollection 2021.
8
Uncovering the Subtype-Specific Molecular Characteristics of Breast Cancer by Multiomics Analysis of Prognosis-Associated Genes, Driver Genes, Signaling Pathways, and Immune Activity.
Front Cell Dev Biol. 2021 Jul 1;9:689028. doi: 10.3389/fcell.2021.689028. eCollection 2021.
9
The link between aberrant splicing and B cell infiltration in breast cancer hormone therapy.
Endocr Relat Cancer. 2022 Mar 24;29(5):251-266. doi: 10.1530/ERC-21-0199.
10
Prognostic alternative splicing events related splicing factors define the tumor microenvironment and pharmacogenomic landscape in lung adenocarcinoma.
Aging (Albany NY). 2022 Aug 24;14(16):6689-6715. doi: 10.18632/aging.204244.
本文引用的文献
1
Alternative splicing of apoptosis genes promotes human T cell survival.
Elife. 2022 Oct 20;11:e80953. doi: 10.7554/eLife.80953.
2
JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles.
Nucleic Acids Res. 2022 Jan 7;50(D1):D165-D173. doi: 10.1093/nar/gkab1113.
3
TISIDB: an integrated repository portal for tumor-immune system interactions.
Bioinformatics. 2019 Oct 15;35(20):4200-4202. doi: 10.1093/bioinformatics/btz210.
4
Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells.
Nature. 2013 Jun 13;498(7453):236-40. doi: 10.1038/nature12172. Epub 2013 May 19.
5
Phosphorylation of ACAP1 by Akt regulates the stimulation-dependent recycling of integrin beta1 to control cell migration.
Dev Cell. 2005 Nov;9(5):663-73. doi: 10.1016/j.devcel.2005.09.012.
Zotero 插件